R&D Pipeline

• Healthcare Professionals
•  
• Patients
•  
• Investors
•  
• Media
•  
• R&D
•  
• Jobs
•  
• Sustainability
•  
• About us

• R&D at a glance
• About R&D
• Pipeline
  • Diabetes
  • Growth Hormone
  • Haemostasis
  • Inflammation
  • Other therapies
• Partnering
• Scientific publications
• Bioethics
• From idea to patient
• Fellowships
• Novo Nordisk Trials
• Contact us

R&D Pipeline

Compound/indication		Phase 1	Phase 2	Phase 3	Filed
Anti-IL20 Inflammation
Anti-C5aR Inflammation
NN8555 Inflammation

Back to top